Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine

Cancer

Volumn 83, Issue 9, 1998, Pages 2008-2014

  Nici, Linda ^a,b   Santos Moore, Anabela ^a   Kuhn, Charles ^a   Calabresi, Paul ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Amifostine; Animal model; Antioxidant; Bleomycin; Lung fibrosis

Indexed keywords

AMIFOSTINE; ANTIOXIDANT; BLEOMYCIN; HYDROXYPROLINE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HAMSTER; HISTOPATHOLOGY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG FIBROSIS; LUNG TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL;

AMIFOSTINE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; BLEOMYCIN; COLLAGEN; CRICETINAE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; MALE; ORGAN SIZE; PULMONARY FIBROSIS;

EID: 0032211299     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981101)83:9<2008::AID-CNCR18>3.0.CO;2-M     Document Type: Article

References (33)

1. Umezawa H, Maeda K, Okami Y. New antibiotics, bleomycin A and B. Cancer 1966;19:21-31.
2. Lazo JS, Sebti SM. Bleomycin. Cancer Chemother Biol Response Modif 1994;15:44-50.
3. Orford J, Barker A, Thonell S, King P, Murphy I. Bleomycin therapy for cystic hygroma. J Pediat Surg 1995;30:1282-7.
4. Bowden DH. Unraveling pulmonary fibrosis. Lab Invest 1984;50:487-8.
5. Martin WJ. Injury from drugs. In: Crystal RG, West JB. The Lung: scientific foundations. New York: Raven Press, 1991:1993-2002.
6. Chandler DB. Possible mechanisms of bleomycin-induced fibrosis. Clin Chest Med 1990;11:21-30.
7. Snider GL, Hayes JA, Korthy AL. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. Am Rev Respir Dis 1978;117:1099-1108.
8. Phan SH. Diffuse interstitial fibrosis. In: Massaro D. Lung cell biology. New York: Marcel Decker, 1989:907-80.
9. Janssen YMW, Heintz NH, Mossman BT. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res 1995;55:2085-9.
10. Capizzi RL. The preclinical basis for the broad spectrum selective cytoprotection of normal tissue from cytotoxic therapies by ethyol. Semin Oncol 1996;23(Suppl 8):2-17.
11. Yuhas JM. Active vs. passive absorption kinetics as a basis for selective cytoprotection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res 1980;40:1519-24.
12. Shaw L, Bonner H, Brown DQ. Metabolic pathways of WR-2721 (Ethyol, amifostine) in the balb/c mouse. Drug Metab Dispos 1994;22:895-902.
13. DeNeve WJ, Everett CK, Suminski JE, Valeriote FA. Influence of WR-2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemic cells in vivo. Cancer Res 1988;48:6002-5.
14. Holwitt EA, Koda E, Swenberg CE. Enhancement of topoisomerase I-mediated unwinding of supercoiled DNA by the radioprotector WR-33278. Radiat Res 1990;124:107-9.
15. DeBruijn EA, Dirix LY, Jorens P, Van Marck E, Van Oosterom AT. Effects of amifostine on bleomycin-induced pulmonary toxicity in a murine model. Proc Annu Meet Am Soc Clin Oncol 1996;15:A1772.
16. Starcher BC, Kuhn C, Overton JE. Increased elastin and collagen content in the lungs of hamsters receiving an intratracheal injection of bleomycin. Am Rev Respir Dis 1978;117:299-305.
17. Pearce ML. Measurement of pulmonary edema. Circ Res 1965;16:482-8.
18. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996;29:225-9.
19. Lazenby AJ, Crouch EC, McDonald JA, Kuhn C. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis 1990;142:206-14.
20. Nici L, Dowin R, Gilmore-Hebert M, Jamieson JD, Ingbar DH. Up-regulation of rat lung Na,K-ATPase during hyperoxic injury. Am J Physiol 261(Lung Cell Mol Physiol 5) 1991:L307-14.
21. McLaughlin GE, Frank L. Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats. Crit Care Med 1994;22:313-9.
22. Polunovsky VA, Baruch C, Henke C, Snover D, Wendt C, Ingbar DH, et al. Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 1993;92:388-97.
23. Abate C, Patel L, Rauscher FJ, Curran T. Redox regulation of fos and jun DNA binding activity in vitro. Science 1990;249:1157-61.
24. Timblin CR, Janssen YWM, Mossman BT. Transcriptional activation of the proto-oncogene c-jun by asbestos and H202 is directly related to increased proliferation and transformation of tracheal epithelial cells. Cancer Res 1995;55:2723-6.
25. Xu J, Brody A, Morris G. Radiation induces p53-mediated activation of proliferating cell nuclear antigen expression in the lung. Am J Respir Crit Care Med 1996;153:A29.
26. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
27. Parizada B, Werber MM, Nimrod A. Protective effect of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun 1991;15:297-301.
28. Wang QJ, Giri SN, Hyde DM. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol 1991;42:1115-22.
29. Shahzeidi S, Sarnstrand B, Jeffrey PK. Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J 1991;4:845-52.
30. Quinlan T, Spivack S, Mossman BT. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 1994;(Suppl 102)2:79-87.
31. Janssen YM, Van Houten B, Borm PJA, Mossman BT. Biology of disease, cell and tissue responses to oxidative damage. Lab Invest 1993;69:261-74.
32. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989;139:370-2.
33. Holley JA, Janssen Y, Mossman BT, Taatjes DJ. Increased manganese superoxide dismutase protein in type II epithelial cells of rat lungs after inhalation of crocidalite asbestos or cristobalite silica. Am J Pathol 1992;141:475-85.